KBC Group NV purchased a new stake in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 3,020 shares of the company’s ...
Hosted on MSN28d
Scholar Rock's chief medical officer sells shares worth $249,935The RSUs, granted on February 12, 2024, vest annually over four years, contingent upon continued service with Scholar Rock.Following this transaction, Marantz holds 67,200 shares, consisting of ...
Wedbush restated their outperform rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research note published on Wednesday,RTT News reports. They currently have a $47.00 target price on ...
Truist Financial analyst Jailendra Singh reiterated a Buy rating on Scholar Rock Holding (SRRK – Research Report) today. The company’s shares closed last Friday at $40.49. Discover ...
Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance. At Scholar Rock Holding Corp, recent insider activity has drawn attention.
Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders ...
CAMBRIDGE, Mass., February 14, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback